Tumor protein could hold key to pancreatic cancer survival

February 23, 2017

But research led by the University of Melbourne reported in the International Journal of Cancer, could eventually improve treatments with the identification of a protein that appears to help tumour cells become more aggressive.

In Australia this year, some 3,200 new cases of Pancreatic cancer will be diagnosed, and 2,900 patients will die of the disease.

University of Melbourne pancreatic surgeon Mehrdad Nikfarjam, and research associates, have identified a protein called p21-activated kinase 1 (PAK1), in specific tumour cells called stellate cells.

Researchers were able to slow down growth and spread of tumors by targeting this protein in stellate cells in animal models, in combination with current chemotherapies.

Stellate cells are responsible for the fibrosis or scarring that surrounds pancreatic tumour cells, reducing the effectiveness of chemotherapy.

The study investigated the role of PAK1 in these stellate cells and how they communicate with the tumour cells.

PAK1 was found to be involved in the fibrotic production, proliferation and death of these cells, and could assist tumour cells to become more aggressive.

Targeting PAK1 resulted in decreased scar tissue formation, reduced tumour growth, increased tumour sensitivity to chemotherapy and increased survival of mice.

Associate Professor Mehrdad Nikfarjam said that although further testing is needed, an inhibitor could potentially increase survival of patients with pancreatic cancer.

"Targeting PAK1 could reduce the fibrosis surrounding pancreatic tumours and allow conventional chemotherapies to have a greater effect on the tumours.

"PAK1's role as an important signalling protein in both the tumour and tumour environment is an important finding in unravelling the puzzle that is pancreatic cancer," Associate Professor Nikfarjam said.
-end-


University of Melbourne

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.